Clinical Trial Update: Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety, tolerability and preliminary efficacy of Etrinabdione in patients with Peripheral artery disease; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Etrinabdione (Etrinabdione)

Snippet

Sponsor: VivaCell Biotechnology España | Conditions: Peripheral Arterial Disease | Phase 2 | Status: NOT_YET_RECRUITING